By Troy Brown, RN
The US Food and Drug Administration (FDA) has cleared for marketing the Simpliciti (Tornier) ultra short-stem shoulder system for arthroplasty in patients with limited shoulder function and severe pain resulting from osteoarthritis or traumatic arthritis, according to a company news release.
The device is a total shoulder arthroplasty system that minimizes bone removal and soft-tissue disruption associated with use of long-stem devices.
“Simpliciti provides upper extremity surgeons with an innovative humeral component, which is intended to deliver the freedoms of precise anatomic placement without the constraints of fixed inclinations, medial offset or posterior offset. Simpliciti is intended to uniquely deliver anatomic results without the procedural complexity of traditional stemmed components,” the news release explains.
